Molecular Biology Enzymes Kits and Reagents Market Growing at a CAGR of 17.8% from 2022 to 2028 Lead by Jena Bioscience, Bioline Technologies, Rockland Immunochemicals

According to our new research study on "Molecular Biology Enzymes, Kits, and Reagents Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product, Application, and End User," the market is expected to reach US$ 41,104.71 million by 2028 from US$ 15,715.48 million in 2022; it is estimated to grow at a CAGR of 17.8% from 2022 to 2028.

The market, by kits & reagents, is further segmented into PCR, lyophilisable and air dryable, NGS, cDNA synthesis, isothermal amplification, DNA extraction, and others. The market, by PCR, is further segmented into Real-time PCR/ quantitative real-time PCR (qPCR), reverse transcriptase PCR (RT-PCR), multiplex PCR, and others.

Get sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPHE100001119/?utm_source=OpenPR&utm_medium=10144

The kits & reagent segment held a larger market share in 2020, and the same segment is estimated to register a higher CAGR during the forecast period. Increasing research and development activities coupled with growing number of product launches drive the market growth for this segment. Moreover, rising utilization of genome sequencing technologies are estimated to propel the demand for reagents & kits, which would ultimately boost the market growth for the reagents & kits segment by 2028.

Based on product, the molecular biology enzymes, kits, and reagents market is bifurcated into enzymes and kits & reagents. The market, by enzymes, is further segmented into polymerases, ligases, reverse transcriptases, phosphatases, proteases and proteinases, restriction endonuclease, and other.

The molecular biology enzymes, kits, and reagents market is witnessing substantial growth amid COVID-19 pandemic. The majority of the healthcare research organizations, market players, and academic centers are actively engaged in the research and development activities to develop new vaccines and therapeutic platforms for novel coronavirus that causes COVID-19. This extensive rise in research and development activities is expected to boost the demand for molecular biology kits and reagents, which, in turn, would drive the growth of the molecular biology enzymes, kits, and reagents market in coming years.

THERMO FISHER SCIENTIFIC INC; Illumina, Inc.; Qiagen; Agilent Technologies, Inc.; F. HOFFMANN-LA ROCHE LTD; Merck KGAA; Jena Bioscience GmbH; Bioline Technologies; Promega Corporation; and Rockland Immunochemicals Inc are among the leading companies operating in the molecular biology enzymes, kits, and reagents market.

Directly Purchase Premium Copy of Molecular Biology Enzymes Kits and Reagents Market Growth Report (2022-2028) at: https://www.theinsightpartners.com/buy/TIPHE100001119/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

This release was published on openPR.